Responsiveness of Lower Airways in Adult Patients (18-60 Years) With Stable Asthma After Treatment With Ciclesonide and Fluticasone Propionate (BY9010/NL-101)
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
18–60
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
History of bronchial asthma
FEV1 \> 1.20 L
Positive Skin Prick Test
Not more than 500 mcg/day fluticasone propionate or equivalent for at least 28 days prior to baseline visit
You may not be if
Clinically relevant abnormal laboratory values
Concomitant severe diseases, diseases expected to interfere with the outcome of the study and diseases which are contra-indications for the use of inhaled steroids
Chronic obstructive pulmonary disease (COPD) and /or other relevant lung diseases
One asthma exacerbation within 2 months or more than 3 exacerbations within the last year prior to baseline visit
Current smokers or ex-smokers with more than 10 pack years, or having smoked within 1 year prior to baseline visit
Positive response to saline challenge at baseline visits
Positive bronchial hyperresponsiveness
Clareo Health | Responsiveness of Lower Airways in Adult Patients (18-60 Years) With Stable Asthma After Treatment With Ciclesonide and Fluticasone Propionate (BY9010/NL-101)
